VBY-891

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameVBY-891
Drug Alias NameVBY-891
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin S inhibitors
TargetsCathepsin S
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVirobay Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirobay IncLeo Pharma Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A